About Matthew Fust
Form D filings for Arsenal Biosciences from 2022 to 2024 list Matthew Fust as director.
Matthew Fust first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Fust in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Fust works with at each company, as listed on that company's latest Form D.
Arsenal Biosciences, Inc. · Form D, Sep 4, 2024
VB
Valentin Barsan
Director
SP
Sean Parker
Director
BB
Brook Byers
Director
JA
James Ahlers
Executive officer
KD
Kenneth Drazan
Executive officer and director
IP
Irene Pleasure
Secretary
BS
Beth Seidenberg
Director